Taking into account all relevant factors, Endo International plc (NASDAQ:ENDP) scores 88% Buy on the technical side. The share price is also flashing a Buy from the Barchart TrendSpotter trading system. Investors starting out on a short-term path of investing should know that short terms indicators for ENDP averaged 100% Buy with an average daily trading volume over the past 20 days at 6438902 shares. Those using medium-term investment strategies, the shares have overall a 1% Buy signal while the 50-day average daily volume remained almost 6849480 shares. It’s also important to note that the stock, whose average daily volume over the 100 days as of this piece was 8462331 shares, is signaling50% Buy for long term investors.
The stock is lingering around the initial support level of $5.49. After this, the following support is at the zone of $5.1. Up until the time the ENDP stock hit levels beyond the current one, bulls should have no alarm. In terms of its momentum, the stock’s RSI hit 69.99 on the daily chart, and this may be a cause for concern. In case the price goes below $5.1 level on closing basis, there may be more profit booking with the stock growing weaker. Still, getting to the $6.19 level may cause a pull-back move approaching $6.5 mark.
Endo International plc (ENDP) is most likely going to rise -12.22 percent in the coming 12 months, as per price target approximations compiled by finviz. Nevertheless, they have set the price target at a $9 as 12-month high price target. This represents a whopping 52.8 percent increase from the current trading price of shares. The 52-week median price target given by the analysts is $4.38, which means a return possibility of -25.64 percent in comparison with the closing price of the stock of $5.89 in recent trading session. The lowest price set for the stock is $3 which is just above -49.07 percent from ENDP share’s price at the end of session.
Let’s take a glimpse at some insider activity at Endo International plc (NASDAQ:ENDP) and observe the pattern. The earliest insider trade happened on 09/16/2019. KIMMEL ROGER H parted with a total of 55 thousand shares of the firm at average share price of $4.09. The total amount for the sale was set at $224.95 thousand. On completing this exchange, the Director account balance was 203.31 thousand shares. The stock grew 40.59 percent from that insider sale. On 06/17/2019, KIMMEL ROGER H, Director, did a sale of 34.95 thousand shares at a price of $3.93 per share. This got rid of 137.36 thousand shares from the insider’s fortune and the stock experienced a 46.31 percent rally in price since the news became public. This exchange saw 258.31 thousand shares get out from the Director account. On 12/10/2018, Director MONTAGUE WILLIAM P recorded a sale transaction valued at $114.1 thousand. The sale at $11.41 a share has eliminated 10 thousand shares from the insider’s portfolio position. Meanwhile, shares price witnessed -49.61 percent decrease since the transaction reporting date. The company insider is left with 64.89 thousand shares remaining in the account. Hutson Nancy J, who works as Director at the company, performed a sale of 10 thousand shares in a transaction worth $128.3 thousand. The disposal recorded on 11/15/2018 was priced at $12.83 per share. The stock price plunged -55.18 percent since the transaction. Hutson Nancy J currently holds a stake of 49.97 thousand in ENDP stock which is worth $294.32 thousand after the insider selling.
In the recent trading session, Endo International plc (NASDAQ:ENDP) shares gained 0.34% or 0.02 points to reach at $5.89 with a thin trading volume of 2.406 million shares. It opened the trading session at $5.45, the shares rose to $6.12 and dropped to $5.42, the range by which the price of stock traded the whole session. The company now has a market cap of $1.29 billion and currently has 219.8 million outstanding shares. Endo International plc (ENDP) stock has accumulated 26.78 percent of market value in 21 trading days.
Stock analysts at Piper Jaffray upped their rating on shares of Endo International plc (NASDAQ:ENDP) from Neutral to a new rating of Overweight in their opinion released on January 03. Morgan Stanley analysts have downgraded their rating of ENDP shares from Equal-Weight to Underweight in a separate flash note to investors on July 15. Analysts at Citigroup downgraded the company stock to a Neutral call from its previous Buy stance, in a flash note that dated back to June 17.
ENDP stock’s trailing 3-year beta is 1.52, meaning there will be a greater rate of return, although posing a higher risk. The part of a firm’s profit given to each outstanding share of regular stock was -$1.83 share in the trailing 52 weeks. The stock’s value surged 25.16 percent year to date (YTD) compared to a decline of -39.04 percent in 52 week’s period. The firm’s shares are still trading -52.84 percent below its 1-year high of $12.49 and 198.98 percent up from 52-week low of $1.97. The average consensus ranking on the company is 3, on a ranging where 5 is equal to a consensus sell rating. In other words, the mean analyst recommendations are ranking this stock as a hold.
Endo International plc (ENDP) shares are trading at a P/E ratio of -2.09 times earnings posted in the trailing 12 months. The industry ENDP deals with has an average P/E of 32.03. Its P/B ratio is standing at -1.46X compared to the 7.25 industry average. It is additionally sporting a 0.25 on the Price-to-Sales ratio, compared to the industry’s P/S average of 0.95. Endo International plc has a 45.4% gross profit margin, with its operating margin around 5.9%. Alongside this, the company’s net profit margin currently stands at -16.9%.
Past records have indicated that shares in Endo International plc rose on 21 different earnings reaction days and we have yet to see whether this trend will play out and remain in place when the company reports upcoming earnings. Investors will get the next hint of ENDP’s Q4 earnings on March 03. Analysts are predicting revenue to suffer decline of -7.2 percent to $730M in the financial fourth quarter, while EPS will soar by about -24 percent to $0.57 per share. In the last quarter, it’s earnings of $0.52 per share came worse than the $0.58948, adjusted, expected by Thomson Reuters consensus estimate. Revenue for the quarter was $786.39M, topping the $738.74M analysts had expected. Earnings are seen to rise by 24.9 percent this year, 1.58 percent in the coming year and the trend continues by -14.63 percent every year in the next 5 years.